Glyceryl Trinitrate
Perfusion; Complications
Wake Forest University Health SciencesPhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Perfusion; Complications cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Indocyanine Green Wake Forest University Health Sciences | Phase 2/3 | B |
Minoxidil Duke University | Phase 1 | CC |
Same molecule, other indications
Glyceryl Trinitrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →